Zhen Huang
Directeur/Bestuurslid bij WALVAX BIOTECHNOLOGY CO., LTD.
Vermogen: 57 M $ op 31-05-2024
Actieve functies van Zhen Huang
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| WALVAX BIOTECHNOLOGY CO., LTD. | Directeur/Bestuurslid | 22-08-2019 | - |
| Corporate Officer/Principal | 01-01-2003 | 22-08-2019 | |
| Yuxi Walvax Biotechnology Co., Ltd. | President | - | - |
Shanghai Zerun Biotechnology Co., Ltd.
 Shanghai Zerun Biotechnology Co., Ltd. BiotechnologyHealth Technology Shanghai Zerun Biotechnology Co., Ltd. engages in the development, commercialization, and industrialization of new recombinant human vaccine products. It develops recombinant vaccines such as preventive cervical cancer vaccines, and recombinant enterovirus 71 virus-like particle and therapeutic vaccines. The company was founded on May 7, 2003 and is headquartered in Shanghai, China. | Directeur/Bestuurslid | - | - |
Loopbaan van Zhen Huang
Statistieken
Internationaal
| China | 4 |
Operationeel
| Director/Board Member | 2 |
| Corporate Officer/Principal | 1 |
| President | 1 |
Sectoraal
| Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| WALVAX BIOTECHNOLOGY CO., LTD. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
| Yuxi Walvax Biotechnology Co., Ltd. | |
Shanghai Zerun Biotechnology Co., Ltd.
Shanghai Zerun Biotechnology Co., Ltd. BiotechnologyHealth Technology Shanghai Zerun Biotechnology Co., Ltd. engages in the development, commercialization, and industrialization of new recombinant human vaccine products. It develops recombinant vaccines such as preventive cervical cancer vaccines, and recombinant enterovirus 71 virus-like particle and therapeutic vaccines. The company was founded on May 7, 2003 and is headquartered in Shanghai, China. | Health Technology |
- Beurs
- Insiders
- Zhen Huang
- Ervaring
